Table 9.
Diagnoses associated with raised faecal calprotectin
| Diagnosis | Patients (%) | Mean age (SEM) | Mean faecal calprotectin (SEM) |
|---|---|---|---|
| Crohn's disease | 31 | 35 (2) | 503.0 (123.9) |
| Ulcerative colitis | 16.5 | 44.9 (3) | 845.3 (394.4) |
| Indeterminate IBD | 9.9 | 43 (3.5) | 187.7 (76.9) |
| Microscopic colitis | 2.2 | 48 (0) | 116 (23.7) |
| NSAID enteropathy | 14.3 | 43 (13.3) | 196.5 (56.8) |
| Gastroenteritis | 8.8 | 40.6 (3.9) | 458.1 (159.4) |
| Diverticular disease | 2.2 | 42 | 278.5 |
| Bacterial overgrowth | 2.2 | 50 | 386.5 |
| Coeliac disease | 2.2 | 44 | 82.5 |
| Postoperative | 2.2 | 58 | 125 |
| Upper gastrointestinal bleed | 1.1 | 27 | 220 |
| Intussusception | 1.1 | 47 | 193 |
| Rectal polyp | 1.1 | 40 | 65 |
| Alcoholic enteropathy | 1.1 | 56 | 99 |
| Solitary rectal ulcer | 1.1 | 21 | 68 |
| Gastrinoma | 1.1 | 48 | 57 |
| Cholecystitis | 1.1 | 18 | 357 |
| Appendicitis | 1.1 | 48 | 190 |
IBD, inflammatory bowel disease; NSAID, non-steroidal anti-inflammatory drug.